skip to content
Detailed Quote
5i Report
Rating
B+

Review of Savaria

AUG 27, 2020 - SIS has recovered nicely from its pandemic lows. Sales have doubled in the past three years and EPS has gained nicely as well. Strong management and material insider ownership also support the case for owning shares. We continue seeing upside and maintain a B+ rating.

Download Report
Company Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions

Q: I've portioned off a smaller amount of my portfolio into a separate unregistered account, reserved for growth names. Currently holding GRN, KRR, PRN, QST, STC, WELL. I have cash for 4 more names, will hold for up to 6 years. I was thinking about SIS. XBC is already held in my TFSA. Can you please suggest 4 growth names to consider that would complement the existing holdings? Thanks.

Read Answer Asked by Dan on February 26, 2021

Q: For New money to initiate positions which 5 stocks in each of the portfolios would you recommend investing. On a related note, is there a reason you dont put buy or hold or buy up to prices in any of the portfolios, or is your stance if it is in there it is a buy regardless of how much a stock may have run up since it was originally recommended.

Read Answer Asked by Aleem on February 19, 2021

Q: I have purchased your Portfolio Analytics tool - so far so good. For my RRSP, I need to increase stock holdings from 2% (average) to 5%. This will assist me to better align my industry allocation while increasing my average stock percentage . Do you feel its a good time/right stocks to bring to a 5% holding - PBH, WSP, WELL and SIS? All are currently at approx. 2% and I have a 17 year investment horizon. If you feel WELL is too much risk can you suggest another health stock?

Read Answer Asked by Don on February 10, 2021
Insiders
Share Information
News and Media